Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort.

scientific article published on 21 June 2016

Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/RHEUMATOLOGY/KEW061
P698PubMed publication ID27330161

P50authorJanet PopeQ48742471
Carol HitchonQ89451273
Vivian P BykerkQ91352262
Boulos HaraouiQ113411649
P2093author name stringGilles Boire
Diane Tin
Carter Thorne
Shahin Jamal
Ed Keystone
CATCH investigators
P2860cites workSo depression is an inflammatory disease, but where does the inflammation come from?Q21245291
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisQ27860872
A new method of classifying prognostic comorbidity in longitudinal studies: development and validationQ29547376
Inconsistent treatment with disease-modifying antirheumatic drugs: a longitudinal data analysisQ30860792
Remission and active disease in rheumatoid arthritis: defining criteria for disease activity statesQ33222832
Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literatureQ33387149
Cardiovascular morbidity and mortality in rheumatoid arthritisQ33806651
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeQ34130671
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatmentQ34563216
Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritisQ34730116
Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES)Q35023431
Increased risk for chronic comorbid disorders in patients with inflammatory arthritis: a population based studyQ35074573
Does the microbiota play a role in the pathogenesis of autoimmune diseases?Q35443254
Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective studyQ35617716
Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health InitiativeQ36001551
Mechanisms of disease: atherosclerosis in autoimmune diseasesQ36577423
Comorbidities in rheumatoid arthritisQ36942648
Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritisQ37177578
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).Q37465556
Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE.Q37883018
From endocrine to rheumatism: do gut hormones play roles in rheumatoid arthritis?Q38123798
Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohortQ38185644
Immune mechanisms linked to depression via oxidative stress and neuroprogressionQ38315020
Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugsQ38471394
Can comorbidity be measured by questionnaire rather than medical record review?Q40940629
Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular diseaseQ44051899
Long-term physical functioning and its association with somatic comorbidity and comorbid depression in patients with established rheumatoid arthritis: a longitudinal studyQ44264105
The Canadian Early Arthritis Cohort (CATCH): patients with new-onset synovitis meeting the 2010 ACR/EULAR classification criteria but not the 1987 ACR classification criteria present with less severe disease activityQ44353678
Validation of a self-report comorbidity questionnaire for multiple sclerosisQ44809985
Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the Canadian Early Arthritis CohortQ44844209
Low prevalence of work disability in early inflammatory arthritis (EIA) and early rheumatoid arthritis at enrollment into a multi-site registry: results from the catch cohortQ45769410
Presence of comorbidity affects both treatment strategies and outcomes in disease activity, physical function, and quality of life in patients with rheumatoid arthritisQ48069664
Psychiatric and cardiovascular comorbidities as causes of long-term work disability among individuals with recent-onset rheumatoid arthritis.Q50616014
Co-morbidities in Finnish patients with rheumatoid arthritis: 15-year follow-up.Q51227331
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectcomorbidityQ1414874
P304page(s)1751-1762
P577publication date2016-06-21
P1433published inRheumatologyQ7320492
P1476titleSelf-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort
P478volume55

Reverse relations

cites work (P2860)
Q90587274Combination of COX-2 inhibitor and metformin attenuates rate of admission in patients with rheumatoid arthritis and diabetes in Taiwan
Q50041216Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis
Q39371685Novel treatment strategies in rheumatoid arthritis.
Q93037024Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial
Q89379251Rheumatoid arthritis: TNF inhibitors and cardiovascular risk management in RA
Q89770369Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

Search more.